Literature DB >> 4132129

Fulminant hepatitis-virus B in a three months old infant: therapeutic trial with specific anti-HB globulins in antibody excess.

J M Dupuy, J L Virelizier, D Frommel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4132129     DOI: 10.1007/bf01638260

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  9 in total

1.  Gamma-globulin for hepatitis-virus B. Prevention or extension?

Authors:  H J Alter; P V Holland; P J Schmidt; P H Plotz
Journal:  Lancet       Date:  1972-05-20       Impact factor: 79.321

2.  Prevention of virus B hepatitis (SH hepatitis).

Authors:  J P Soulier; C Blatix; A M Courouce; D Benamon; P Amouch; J Drouet
Journal:  Am J Dis Child       Date:  1972-04

3.  Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1971-12-13       Impact factor: 56.272

4.  [Radioimmunological determination of Australia antigen].

Authors:  P J Amouch; J Drouet
Journal:  Nouv Rev Fr Hematol       Date:  1971 Jul-Aug

Review 5.  Experimental glomerulonephritis: immunological events and pathogenetic mechanisms.

Authors:  E R Unanue; F J Dixon
Journal:  Adv Immunol       Date:  1967       Impact factor: 3.543

6.  Fulminant hepatitis treated with serum containing antibody to Australia antigen.

Authors:  D J Gocke
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

7.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

8.  Viral hepatitis, type B (MS-2 strain). Detection of antibody after primary infection.

Authors:  J J Lander; J P Giles; R H Purcell; S Krugman
Journal:  N Engl J Med       Date:  1971-08-05       Impact factor: 91.245

9.  Antibody against serum-hepatitis antigen. Prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections.

Authors:  A M Prince; W Szmuness; K R Woods; G F Grady
Journal:  N Engl J Med       Date:  1971-10-21       Impact factor: 91.245

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.